Six Tech-Focused Startups Selected as Finalists for Diabetes Innovation Competition

CHICAGO, Nov. 3, 2017 /PRNewswire-USNewswire/ -- On Tuesday, November 7, six finalists will compete in the American Diabetes Association's (ADA) second-annual Venture to Stop Diabetes Challenge, a competition to identify emerging, innovative solutions for improved diabetes prevention and management. The finalists' submissions represent opportunities to simplify, enhance and increase access to diabetes treatment and care.

The 2017 finalists were selected from applicants in the U.S. and internationally, based upon the following criteria: relevance, creativity and innovation, feasibility and sustainability, and organization and clarity. Proposals will be judged by a panel of stakeholders in the diabetes ecosystem, including ADA leadership, innovation incubators, corporate investment leaders, and the private insurance industry. The winning submission will receive positive alignment with the ADA and favorable introductions to ADA sponsors and partners in an effort to bring the product to market.

The 2017 finalists include:

• DiaBits, Developed by Bio Conscious Technologies
  Vancouver, BC, Canada
  Concept: Reducing the guesswork associated with managing diabetes by integrating CGM and wearable data, and using machine learning to predict future glucose values ahead of time.
  
  
• EyeLogic
  San Francisco, CA
  Concept: Instant, smartphone-based detection of eye disease.
  
  
• Glucair, Developed by New England Breath Technologies, Inc.
  Springfield, MA
  Concept: A non-invasive glucose monitor using breath analysis instead of blood for enhanced compliance and simplified diabetes management.
  
  
• Kaizen Health
  Chicago, IL
  Concept: A web-based platform that brings together diverse fleets to arrange medical transportation for patients in need.
  
  
• NowPow
  Chicago, IL
  Concept: A technology platform that empowers care professionals to promote high quality community resources to their patients, provide data-driven referrals, and track client engagement and activation.
  
  
• Saturn Care Chronic Disease Management Program  (CDMP)
  Conshohocken, PA
  Concept: An evidence-based program that facilitates primary care capacity to prevent complications in patients with diabetes.

WHAT: American Diabetes Association Venture to Stop Diabetes Challenge

WHEN: Tuesday, November 7, 2017 at 6:00 p.m. CT

WHERE: mHub Chicago
965 W. Chicago Ave.
Chicago, IL 60642

CONTACT: Members of the media interested in covering this event should contact Erin Callahan at [email protected] or (773) 620-5098

This event is open to the public. Interested individuals may register at www.adaventure2017.eventbrite.com  

The 2016 champion, POPS! Diabetes Care, has since raised more than $1 million in funding to accelerate its product to market and has begun enrolling candidates in clinical trials. For more information on the "Venture to Stop Diabetes Challenge" and the ADA's innovation initiatives, please visit adainnovation.org.

About the American Diabetes Association
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation's leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).

SOURCE American Diabetes Association

Related Links

http://www.diabetes.org